Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for June 23rd, 2012

« Older Entries

Ask a Best Doctor: The Death Trap of Sitting, Soy Milk vs. Skim, and Decoding Panic Attacks

By on Saturday, June 23rd, 2012 | No Comments

I keep seeing headlines about how sitting all day will give you heart disease. I work at a desk from 10 a.m. till 8 p.m., five days a week; am I really going to die an early death? And please, don’t tell me to get a standing desk – not going to happen.

Read More...

GMCSF linked with rapid cognitive recovery in patients with cancer

By on Saturday, June 23rd, 2012 | No Comments

Growth factors shown to cure Alzheimer’s disease in a mouse model and administered to cancer patients as part of their treatment regimen were linked to significant improvements in the patients’ cognitive function following stem cell transplantation, a preliminary clinical study reports.

Read More...

More women beating breast cancer

By on Saturday, June 23rd, 2012 | No Comments

Breast cancer survivor Sharon Schroeter was left wondering after there was no follow-up care when her treatment cycle ended.

Read More...

NBC Los Angeles: Prostate Cancer Survivor Gabe Canales, Sep 2011

By on Saturday, June 23rd, 2012 | No Comments

www.BlueCure.org Gabe Canales is a prostate cancer survivor. He joins Colleen Williams on Nonstop News LA to share his story and his mission to spread awareness. From Gabe Canales – HUFFINGTON POST Fight Cancer With Facebook by Gabe Canales http Prostate Cancer Prevention Begins When Men Are Boys by Gabe Canales www.huffingtonpost.com Fight Prostate Cancer With Meatless Monday by Gabe Canales www.huffingtonpost.com Part II – Why Men Should Consider an Integrative Approach to Prostate Cancer by Gabe Canales www.huffingtonpost.com Part I – Why Men Should Consider an Integrative Approach to Prostate Cancer by Gabe Canales www.huffingtonpost.com CyberKnife? 5 Questions on Prostate Cancer With Dr. Jonathan Haas by Gabe Canales www.huffingtonpost.com ‘Celts for Blue Cure’ to Fight Prostate Cancer — Will Other Schools Follow? by Gabe Canales www.huffingtonpost.com Presidential Politics and ‘The War on Cancer’ by Gabe Canales www.huffingtonpost.com Why You Should ‘Go Blue!’ to Fight Prostate Cancer by Gabe Canales www.huffingtonpost.com An Open Letter to the NFL: Why We Can’t Neglect Prostate Cancer by Gabe Canales www.huffingtonpost.com Prostate Cancer: Not Just an Old Man’s Cancer by Gabe Canales www.huffingtonpost.com more links at www.BlueCure.org Please join me in the fight to end prostate cancer! Sign up and make a difference at http

Read More...

Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy

By on Saturday, June 23rd, 2012 | No Comments

Condition :   Diffuse Large B-Cell Lymphoma Interventions :   Drug: Bendamustine;   Drug: Ofatumumab Sponsors :   Sarah Cannon Research Institute;   Sarah Cannon Research Institute;   GlaxoSmithKline;   Cephalon Not yet recruiting – verified June 2012

Read More...

Reduction of Perineal Pain After Vaginal Birth With Black Tea: Pilot Randomized Study

By on Saturday, June 23rd, 2012 | No Comments

Condition :   Perineal Pain Interventions :   Other: Frozen perineal pad;   Other: Warm water soaked Black Tea Bags Sponsors :   Fraser Health;   Fraser Health Not yet recruiting – verified June 2012

Read More...

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders

By on Saturday, June 23rd, 2012 | No Comments

Conditions :   Lysosomal Storage Disease;   Peroxisomal Disorder Interventions :   Drug: Campath-1H;   Drug: Clofarabine;   Drug: Melphalan;   Radiation: Total Body Irradiation with Marrow Boosting;   Biological: Hematopoietic stem cell transplantation;   Drug: Cyclosporine A;   Drug: Mycophenylate Mofetil Sponsors :   Masonic Cancer Center, University of Minnesota;   Masonic Cancer Center, University of Minnesota Not yet recruiting – verified June 2012

Read More...

CRLX101 Plus Bevacizumab in Advanced RCC

By on Saturday, June 23rd, 2012 | No Comments

Condition :   Renal Cell Carcinoma Interventions :   Drug: CRLX101 (Cerulean);   Drug: Bevacizumab Sponsors :   Abramson Cancer Center of the University of Pennsylvania;   Abramson Cancer Center of the University of Pennsylvania Recruiting – verified June 2012

Read More...

Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma

By on Saturday, June 23rd, 2012 | No Comments

Condition :   Sarcoma Interventions :   Genetic: DNA methylation analysis;   Genetic: RNA analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: polymorphism analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis Sponsors :   National Cancer Institute (NCI);   Children’s Oncology Group;   National Cancer Institute (NCI) Active, not recruiting – verified June 2012

Read More...

Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia

By on Saturday, June 23rd, 2012 | No Comments

Condition :   Leukemia Interventions :   Genetic: RNA analysis;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis Sponsors :   National Cancer Institute (NCI);   Children’s Oncology Group;   National Cancer Institute (NCI) Active, not recruiting – verified June 2012

Read More...
« Older Entries